Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Elizabeth McFarland

Concepts (375)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
838
2.940
Why?
HIV Infections
48
2025
2730
2.930
Why?
Respiratory Syncytial Virus Vaccines
6
2022
34
2.390
Why?
Respiratory Syncytial Virus Infections
6
2022
120
2.200
Why?
Respiratory Syncytial Virus, Human
6
2022
69
2.180
Why?
Infectious Disease Transmission, Vertical
18
2025
171
2.170
Why?
HIV Antibodies
12
2025
57
2.080
Why?
Anti-Retroviral Agents
12
2023
231
1.760
Why?
Viral Proteins
3
2020
327
1.610
Why?
Antibodies, Viral
8
2022
602
1.150
Why?
Antibodies, Neutralizing
8
2025
267
1.120
Why?
Antibodies, Monoclonal
6
2025
1366
0.900
Why?
Anti-HIV Agents
11
2025
757
0.890
Why?
AIDS Vaccines
8
2018
47
0.870
Why?
Pregnancy Complications, Infectious
8
2016
368
0.780
Why?
Gene Deletion
2
2020
382
0.740
Why?
Breast Feeding
4
2025
423
0.660
Why?
Atazanavir Sulfate
2
2017
41
0.650
Why?
HIV Protease Inhibitors
2
2017
68
0.630
Why?
Ritonavir
2
2017
73
0.630
Why?
Vaccination
6
2020
1347
0.600
Why?
Infant, Newborn
23
2025
5756
0.590
Why?
Vaccines, Attenuated
6
2022
125
0.590
Why?
HIV Envelope Protein gp120
6
2017
57
0.590
Why?
Infant
31
2025
8995
0.530
Why?
Nelfinavir
1
2016
9
0.520
Why?
Lopinavir
1
2016
30
0.510
Why?
Syncope
1
2016
51
0.500
Why?
Patient Dropouts
1
2016
64
0.500
Why?
Bradycardia
1
2016
53
0.500
Why?
Lyme Disease
1
2016
57
0.490
Why?
Health Resources
1
2016
113
0.480
Why?
Infant, Newborn, Diseases
1
2016
110
0.450
Why?
HIV
5
2014
227
0.430
Why?
Patient Compliance
2
2018
565
0.410
Why?
Child
37
2025
20884
0.390
Why?
Immunogenicity, Vaccine
4
2021
27
0.390
Why?
CD4-Positive T-Lymphocytes
2
2017
1058
0.360
Why?
T-Lymphocytes, Cytotoxic
4
2005
170
0.360
Why?
Humans
72
2025
129625
0.360
Why?
Virus Replication
4
2020
452
0.360
Why?
Female
48
2025
68734
0.350
Why?
Lymphocyte Activation
5
2017
1109
0.320
Why?
Male
39
2025
63670
0.310
Why?
Adolescent
27
2025
20412
0.300
Why?
Viral Load
9
2017
449
0.290
Why?
HIV Seropositivity
2
2023
119
0.280
Why?
Bone Density
2
2025
463
0.280
Why?
Double-Blind Method
3
2020
1875
0.270
Why?
RNA, Viral
8
2023
620
0.260
Why?
Antibodies, Bacterial
2
2018
139
0.250
Why?
Antiretroviral Therapy, Highly Active
6
2017
267
0.240
Why?
Dyslipidemias
2
2017
177
0.240
Why?
Bone Development
1
2025
50
0.240
Why?
Immunoenzyme Techniques
1
2005
212
0.230
Why?
Immunoglobulin G
3
2022
851
0.220
Why?
Colonography, Computed Tomographic
1
2024
6
0.220
Why?
Viremia
3
2011
131
0.220
Why?
Diverticulum
1
2024
11
0.220
Why?
Child, Preschool
21
2022
10490
0.220
Why?
Gene Products, gag
2
1994
36
0.220
Why?
Mammography
1
2025
146
0.210
Why?
Young Adult
12
2021
12455
0.210
Why?
Pregnancy
11
2023
6417
0.210
Why?
Squalene
3
2017
7
0.200
Why?
Complementarity Determining Regions
1
2002
49
0.200
Why?
Drug Resistance, Viral
2
2016
110
0.190
Why?
CD4 Lymphocyte Count
4
2017
267
0.190
Why?
Half-Life
1
2021
162
0.190
Why?
Growth Differentiation Factor 15
1
2021
40
0.190
Why?
Mitochondrial Diseases
1
2021
90
0.180
Why?
Immunization Schedule
2
2018
197
0.180
Why?
T-Lymphocytes
2
2009
1936
0.170
Why?
Drug Therapy, Combination
4
2017
1042
0.170
Why?
Fibroblast Growth Factors
1
2021
169
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
336
0.170
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
183
0.160
Why?
Cytokines
2
2021
2021
0.160
Why?
Body Temperature
1
2020
212
0.160
Why?
Point Mutation
1
2020
224
0.150
Why?
Insulin Resistance
3
2019
1167
0.150
Why?
Immunologic Memory
2
2021
349
0.150
Why?
Haemophilus Vaccines
2
2018
28
0.150
Why?
Immunocompromised Host
2
2000
199
0.150
Why?
Metabolic Syndrome
1
2021
340
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
855
0.140
Why?
Interleukin-12
1
1998
118
0.140
Why?
Darunavir
1
2017
18
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
353
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Dose-Response Relationship, Drug
1
2021
2011
0.140
Why?
Interferon-gamma
5
2012
772
0.140
Why?
Lymphopoiesis
1
2017
26
0.130
Why?
Uganda
1
2017
70
0.130
Why?
Immunoglobulin A
2
2017
202
0.130
Why?
Antibody Formation
1
2018
291
0.130
Why?
High-Throughput Screening Assays
1
2018
139
0.130
Why?
Receptors, CCR5
1
2017
57
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
Why?
Cohort Studies
8
2025
5426
0.130
Why?
Adoption
1
2016
32
0.130
Why?
Mothers
3
2017
731
0.130
Why?
Virus Latency
1
2016
84
0.120
Why?
Continuity of Patient Care
1
2018
273
0.120
Why?
Adult
15
2023
35599
0.120
Why?
Chickenpox Vaccine
1
2015
71
0.120
Why?
Early Diagnosis
1
2016
233
0.120
Why?
Body Height
2
2017
192
0.120
Why?
Zimbabwe
2
2025
53
0.120
Why?
Gene Products, env
1
1994
6
0.120
Why?
Disease Susceptibility
1
2017
334
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.120
Why?
Bacterial Capsules
1
2014
28
0.120
Why?
Chickenpox
1
2015
80
0.120
Why?
Antibody Affinity
1
2014
59
0.110
Why?
South Africa
2
2025
192
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
228
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
284
0.110
Why?
Lipids
1
2017
627
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Cytotoxicity, Immunologic
3
2002
220
0.110
Why?
Intestines
1
2017
347
0.110
Why?
Leukocytes, Mononuclear
4
2013
546
0.110
Why?
Retrospective Studies
8
2023
14522
0.110
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Vaccines
1
2018
400
0.100
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Patient Selection
1
2017
661
0.100
Why?
Breast Neoplasms
1
2025
2133
0.100
Why?
Lamivudine
3
2023
61
0.100
Why?
Mitochondria
2
2021
876
0.100
Why?
Cell Movement
1
2017
948
0.100
Why?
Child Development
1
2017
460
0.100
Why?
Pediatric Obesity
1
2019
573
0.100
Why?
Clinical Trials as Topic
1
2017
1005
0.100
Why?
Cardiovascular Diseases
2
2016
2006
0.100
Why?
STAT1 Transcription Factor
1
2012
69
0.090
Why?
Prospective Studies
4
2017
7135
0.090
Why?
Body Weight
2
2017
940
0.090
Why?
Polysorbates
3
2017
39
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Mycobacterium avium Complex
1
2012
88
0.090
Why?
Epitopes
2
2022
472
0.090
Why?
United States
9
2023
13871
0.090
Why?
Cost-Benefit Analysis
2
2025
569
0.090
Why?
Biomedical Research
1
2017
640
0.090
Why?
Research Design
1
2017
1045
0.090
Why?
Exercise
1
2021
1928
0.080
Why?
Interleukin-2
2
2003
437
0.080
Why?
Respiratory Tract Infections
1
2014
376
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
574
0.080
Why?
Freezing
1
2009
87
0.080
Why?
Absorptiometry, Photon
2
2025
248
0.080
Why?
Blood
1
2009
105
0.080
Why?
Algorithms
1
2016
1616
0.080
Why?
Staff Development
1
2009
55
0.070
Why?
Age Factors
4
2019
3152
0.070
Why?
Phenotype
1
2017
3075
0.070
Why?
Longitudinal Studies
3
2025
2720
0.070
Why?
T-Lymphocyte Subsets
2
2002
412
0.070
Why?
Biomarkers
4
2021
3968
0.070
Why?
Specimen Handling
1
2009
162
0.070
Why?
Lymphocyte Subsets
2
2009
84
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
834
0.070
Why?
Faculty
1
2009
137
0.070
Why?
Withholding Treatment
1
2008
71
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Adipose Tissue
1
2011
591
0.070
Why?
Polymerase Chain Reaction
4
2011
1035
0.060
Why?
Central Nervous System Viral Diseases
1
2007
73
0.060
Why?
Academic Medical Centers
1
2009
475
0.060
Why?
DNA, Viral
2
2000
347
0.060
Why?
Flow Cytometry
3
2009
1159
0.060
Why?
False Negative Reactions
1
2025
53
0.060
Why?
Cell Line
3
2012
2784
0.060
Why?
Isoantigens
1
1984
13
0.060
Why?
Medical Audit
1
2025
74
0.060
Why?
Enterovirus Infections
1
2007
171
0.060
Why?
C-Reactive Protein
2
2021
400
0.060
Why?
Colorado
3
2023
4404
0.060
Why?
Immunity, Cellular
1
2006
265
0.060
Why?
Disease Outbreaks
1
2007
349
0.060
Why?
Follow-Up Studies
3
2021
4894
0.060
Why?
Linear Models
2
2020
819
0.060
Why?
Comorbidity
2
2021
1547
0.050
Why?
Confusion
1
2024
28
0.050
Why?
Sequence Analysis, DNA
2
2007
778
0.050
Why?
Thymus Gland
1
1984
308
0.050
Why?
Risk Factors
4
2021
9786
0.050
Why?
Tablets
1
2023
35
0.050
Why?
Constriction, Pathologic
1
2024
234
0.050
Why?
Regression Analysis
2
2021
997
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
21
0.050
Why?
Immunophenotyping
2
1994
311
0.050
Why?
Zidovudine
2
2015
78
0.050
Why?
Clone Cells
1
2002
262
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
Why?
Cough
1
2022
116
0.050
Why?
Emtricitabine
1
2023
168
0.050
Why?
Vaccines, Subunit
1
2001
48
0.050
Why?
Pyridones
1
2023
158
0.050
Why?
Tenofovir
1
2023
232
0.050
Why?
Lung
1
2014
3938
0.040
Why?
Clinical Trials, Phase I as Topic
1
2021
51
0.040
Why?
Public Health Surveillance
1
2021
68
0.040
Why?
Ganciclovir
1
2000
52
0.040
Why?
Computer Simulation
1
2005
939
0.040
Why?
Adjuvants, Immunologic
2
2017
221
0.040
Why?
Africa
1
2020
99
0.040
Why?
Cross-Sectional Studies
3
2021
5075
0.040
Why?
Injections, Subcutaneous
1
2020
147
0.040
Why?
Sex Factors
2
2019
1970
0.040
Why?
Diagnostic Tests, Routine
1
2021
104
0.040
Why?
Symptom Assessment
1
2021
125
0.040
Why?
HIV Seronegativity
1
2019
25
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
855
0.040
Why?
Case-Control Studies
2
2019
3378
0.040
Why?
Prevalence
2
2016
2564
0.040
Why?
Cytomegalovirus Infections
1
2000
189
0.040
Why?
Hospitals
1
2023
637
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
50
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Cholesterol, HDL
1
2019
205
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Amino Acid Sequence
1
2002
2057
0.040
Why?
Mutation
3
2018
3717
0.040
Why?
Odds Ratio
1
2021
1019
0.040
Why?
Hepatitis B Vaccines
1
2018
47
0.040
Why?
Drug Resistance, Microbial
2
2000
69
0.040
Why?
Molecular Sequence Data
1
2002
2835
0.040
Why?
Nutrition Surveys
1
2019
260
0.040
Why?
Case Management
1
2018
63
0.040
Why?
Antigens, Viral
1
1998
179
0.030
Why?
Cholesterol
1
2019
412
0.030
Why?
Cholesterol, LDL
1
2019
358
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
186
0.030
Why?
Reproducibility of Results
1
2005
3080
0.030
Why?
Disease Management
1
2021
588
0.030
Why?
Immune Tolerance
1
1999
356
0.030
Why?
Treatment Adherence and Compliance
1
2017
24
0.030
Why?
Triglycerides
1
2019
528
0.030
Why?
Lymphocyte Count
2
2009
148
0.030
Why?
Cell Division
1
1998
796
0.030
Why?
Uncertainty
1
2017
121
0.030
Why?
Treatment Failure
1
2017
339
0.030
Why?
Multicenter Studies as Topic
1
2017
286
0.030
Why?
Nevirapine
1
2015
17
0.030
Why?
Time-to-Treatment
1
2017
179
0.030
Why?
Seroepidemiologic Studies
1
2015
157
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1365
0.030
Why?
Maternal Exposure
1
2017
177
0.030
Why?
Malnutrition
1
2016
79
0.030
Why?
Patient Outcome Assessment
1
2016
126
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Antiviral Agents
1
2000
715
0.030
Why?
Treatment Outcome
2
2021
10219
0.030
Why?
Coinfection
1
2016
131
0.030
Why?
Neutropenia
1
2015
137
0.030
Why?
Vaccines, Conjugate
1
2014
63
0.030
Why?
Counseling
1
2018
386
0.030
Why?
Sexual and Gender Minorities
1
2018
196
0.030
Why?
Global Health
1
2017
328
0.030
Why?
Cells, Cultured
2
2008
4084
0.030
Why?
Anemia
1
2015
161
0.030
Why?
Maternal-Fetal Exchange
1
2014
162
0.030
Why?
Electron Transport Complex IV
1
2013
57
0.030
Why?
Electron Transport Complex I
1
2013
39
0.030
Why?
Thrombocytopenia
1
2015
186
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
30
0.030
Why?
CD8 Antigens
1
1993
75
0.030
Why?
Radiography, Thoracic
1
2014
166
0.030
Why?
Severity of Illness Index
1
2021
2739
0.030
Why?
CD3 Complex
1
1993
102
0.030
Why?
Drug Administration Schedule
2
2008
767
0.020
Why?
Lymphocytes
1
1994
378
0.020
Why?
Oxidative Phosphorylation
1
2013
188
0.020
Why?
Medication Adherence
1
2017
558
0.020
Why?
Blood Pressure
1
2019
1736
0.020
Why?
DNA, Mitochondrial
1
2013
191
0.020
Why?
Blood Transfusion
1
1994
295
0.020
Why?
P-Selectin
1
2011
27
0.020
Why?
Antigens, CD
1
1994
487
0.020
Why?
E-Selectin
1
2011
55
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
135
0.020
Why?
Hospitalization
1
2021
2057
0.020
Why?
Chemokine CCL2
1
2011
117
0.020
Why?
Cell Proliferation
2
2009
2373
0.020
Why?
Hyperlipidemias
1
2011
126
0.020
Why?
Fibrinogen
1
2011
163
0.020
Why?
Protein Multimerization
1
2012
179
0.020
Why?
Interferon-alpha
1
2012
194
0.020
Why?
Cross Infection
1
1993
217
0.020
Why?
Nontuberculous Mycobacteria
1
1993
204
0.020
Why?
Cell Adhesion Molecules
1
2011
173
0.020
Why?
Healthcare Disparities
1
2017
578
0.020
Why?
Infant, Premature
1
1994
542
0.020
Why?
Diagnosis, Differential
1
2014
1432
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
L-Selectin
1
2009
25
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
37
0.020
Why?
Leukocyte Common Antigens
1
2009
82
0.020
Why?
Obesity
1
2021
2882
0.020
Why?
Multivariate Analysis
1
2011
1499
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
28
0.020
Why?
Interleukin-6
1
2011
723
0.020
Why?
Phosphorylation
1
2012
1713
0.020
Why?
Data Interpretation, Statistical
1
2009
337
0.020
Why?
Pregnancy Outcome
1
2010
391
0.020
Why?
Cerebrospinal Fluid
1
2007
91
0.020
Why?
Paralysis
1
2007
69
0.020
Why?
Multiple Organ Failure
1
2007
123
0.020
Why?
B-Lymphocytes
1
2012
816
0.020
Why?
Kinetics
1
2010
1645
0.020
Why?
Genotype
1
2011
1833
0.020
Why?
Respiratory System
1
2007
155
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Cell Survival
1
2009
1076
0.020
Why?
Phosphates
1
1987
179
0.020
Why?
Muscles
1
1987
320
0.020
Why?
Encephalitis
1
2007
132
0.020
Why?
Gastrointestinal Tract
1
2007
186
0.010
Why?
Mucous Membrane
1
2005
125
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
52
0.010
Why?
Chemical Phenomena
1
1984
82
0.010
Why?
DNA-Binding Proteins
1
2012
1445
0.010
Why?
Myasthenia Gravis
1
1984
21
0.010
Why?
Tomography, X-Ray Computed
1
2014
2512
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
64
0.010
Why?
Saliva
1
2005
211
0.010
Why?
Tissue Distribution
1
1984
315
0.010
Why?
Aging
2
2003
1778
0.010
Why?
Blood Glucose
1
2013
2100
0.010
Why?
Epithelium
1
1984
314
0.010
Why?
Middle Aged
2
2020
31136
0.010
Why?
Body Mass Index
1
2011
2274
0.010
Why?
Anti-Bacterial Agents
1
1993
1705
0.010
Why?
Infusions, Intravenous
1
2003
399
0.010
Why?
Reference Values
1
2003
794
0.010
Why?
Mice, Inbred BALB C
1
1984
1250
0.010
Why?
Suspensions
1
2000
36
0.010
Why?
Capsules
1
2000
40
0.010
Why?
Urban Population
1
2003
443
0.010
Why?
Drug Tolerance
1
2000
90
0.010
Why?
Cytomegalovirus
1
2000
154
0.010
Why?
Signal Transduction
1
2012
4931
0.010
Why?
Administration, Oral
1
2000
787
0.010
Why?
Epithelial Cells
1
1984
1075
0.010
Why?
Immunization
1
2000
411
0.010
Why?
Time Factors
1
2008
6555
0.010
Why?
Macrophages
1
1984
1488
0.010
Why?
Recombinant Proteins
1
2000
1308
0.010
Why?
Mice
1
1984
16961
0.000
Why?
Tail
1
1987
28
0.000
Why?
Phosphocreatine
1
1987
43
0.000
Why?
Salamandridae
1
1987
27
0.000
Why?
Animals
2
1987
35391
0.000
Why?
Aged
1
1984
22061
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
539
0.000
Why?
Adenosine Triphosphate
1
1987
479
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)